Mergers and acquisitions involving domestic companies jumped to the highest level since 2011 to USD 26.1 billion during the first nine months this year.
The amount is up 16.5 per cent from the year-ago period.
During the first three quarters of 2011, the domestic M&A market had stood at USD 34.5 billion, according to the data collated by Thomson Reuters.
Also Read
The average M&A deal size climbed to USD 75.2 million in the January-September period, against USD 63.1 million a year ago as most deals were in the USD 500 million-plus range.
Out of this, domestic deals accounted for USD 11.1 billion, up 206.6 per cent over 2103, due to Sun Pharmaceutical's pending acquisition of Ranbaxy for USD 4.1 billion. The deal pushed the healthcare sector to capture 40.3 per cent of domestic deal activity.
However, total cross-board M&As plunged 40.2 per cent to USD 10.7 billion from the last year levels as both inbound and outbound activity declined. While inbound deals fell 24.6 per cent, outbound deals plummeted 70.2 per cent over the same period last year.
Total worth of completed deals amounted to USD 21.6 billion, up by 3.6 per cent to USD 22.4 billion in 2013.
Healthcare deals topped the deal street in market share with 23.2 per cent at USD 6.1 billion, an increase of 145.8 per cent increase from the first nine of 2013, making it the highest since 2008 when it stood at USD 6.2 billion.
Energy and power sector followed next with 14.4 per cent of the deals at USD 3.7 billion, but down to 39.8 per cent from the same period last year.
Technology, media, and telecom sector together managed a market share of 16.7 per cent at USD 4.3 billion from the first nine months of 2013, up by 35 per cent.
